SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Guilherme Alcantara Cunha Lima, Francisco de Paula Paranhos-Neto, Luciana Colonese Silva, Laura Maria Carvalho de Mendonça, Alvimar Gonçalves Delgado, Maurilo Leite, Carlos Perez Gomes, Maria Lucia Fleiuss Farias, Bone Density Is Directly Associated With Glomerular Filtration and Metabolic Acidosis but Do Not Predict Fragility Fractures in Men With Moderate Chronic Kidney Disease, Journal of Clinical Densitometry, 2016, 19, 2, 146

    CrossRef

  2. 2
    Cai-Mei Zheng, Jin-Quan Zheng, Chia-Chao Wu, Chien-Lin Lu, Jia-Fwu Shyu, Hsu Yung-Ho, Mei-Yi Wu, I-Jen Chiu, Yuan-Hung Wang, Yuh-Feng Lin, Kuo-Cheng Lu, Bone loss in chronic kidney disease: Quantity or quality?, Bone, 2016, 87, 57

    CrossRef

  3. 3
    Jarinthorn Teerapornpuntakit, Kannikar Wongdee, Nateetip Krishnamra, Narattaphol Charoenphandhu, Expression of osteoclastogenic factor transcripts in osteoblast-like UMR-106 cells after exposure to FGF-23 or FGF-23 combined with parathyroid hormone, Cell Biology International, 2016, 40, 3
  4. 4
    Alexis Jozefacki, Christine A. White, Navid S. Shobeiri, Wilma M. Hopman, Amer M. Johri, Michael A. Adams, Rachel M. Holden, Phosphate excretion is decreased in older cardiac patients with normal kidney function: an emerging dietary risk factor?, Applied Physiology, Nutrition, and Metabolism, 2016, 41, 4, 452

    CrossRef

  5. 5
    Ibón Santos, María Arango, Andrés Pérez, Utilidad del factor de crecimiento fibroblástico 23 en la prevención de enfermedades cardiovasculares en pacientes con enfermedad renal crónica, Revista Colombiana de Cardiología, 2016,

    CrossRef

  6. 6
    T. Montalcini, P. Gallotti, A. Coppola, V. Zambianchi, M. Fodaro, E. Galliera, M. G. Marazzi, S. Romeo, S. Giannini, M. M. Corsi Romanelli, A. Pujia, C. Gazzaruso, Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes, Osteoporosis International, 2015, 26, 5, 1639

    CrossRef

  7. 7
    Olena Andrukhova, Svetlana Slavic, Kathrin I Odörfer, Reinhold G Erben, Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23, Journal of Bone and Mineral Research, 2015, 30, 10
  8. 8
    Yu-Chen Guo, Quan Yuan, Fibroblast growth factor 23 and bone mineralisation, International Journal of Oral Science, 2015, 7, 1, 8

    CrossRef

  9. 9
    Ana Paula Silva, Kristina Gundlach, Janine Büchel, Teresa Jerónimo, André Fragoso, Claudia Silva, Patrícia Guilherme, Nélio Santos, Marília Faísca, Pedro Neves, Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic Patients, International Journal of Endocrinology, 2015, 2015, 1

    CrossRef

  10. 10
    Zhi-jian Sun, Jin Jin, Gui-xing Qiu, Peng Gao, Yong Liu, Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors, BMC Musculoskeletal Disorders, 2015, 16, 1, 43

    CrossRef

  11. 11
    Paul D. Miller, Sophie Jamal, Stuart M. Sprague, The Parathyroids, 2015,

    CrossRef

  12. 12
    Paul D. Miller, Bone Disease in CKD: A Focus on Osteoporosis Diagnosis and Management, American Journal of Kidney Diseases, 2014, 64, 2, 290

    CrossRef

  13. 13
    Paul D Miller, Chronic kidney disease and osteoporosis: evaluation and management, BoneKEy Reports, 2014, 3,

    CrossRef

  14. 14
    Paul D Miller, Chronic kidney disease and the skeleton, Bone Research, 2014, 2, 14044

    CrossRef

  15. 15
    Farhad Zangeneh, Bart Clarke, Daniel Hurley, Nelson Watts, Paul Miller, Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBDs): What the Endocrinologist Needs to Know, Endocrine Practice, 2014, 20, 5, 500

    CrossRef

  16. 16
    Mitchell H. Rosner, Alan C. Dalkin, Electrolyte Disorders Associated With Cancer, Advances in Chronic Kidney Disease, 2014, 21, 1, 7

    CrossRef

  17. 17
    Olena Andrukhova, Alina Smorodchenko, Monika Egerbacher, Carmen Streicher, Ute Zeitz, Regina Goetz, Victoria Shalhoub, Moosa Mohammadi, Elena E Pohl, Beate Lanske, Reinhold G Erben, FGF23 promotes renal calcium reabsorption through the TRPV5 channel, The EMBO Journal, 2014, 33, 3
  18. 18
    Olena Andrukhova, Svetlana Slavic, Alina Smorodchenko, Ute Zeitz, Victoria Shalhoub, Beate Lanske, Elena E Pohl, Reinhold G Erben, FGF23 regulates renal sodium handling and blood pressure, EMBO Molecular Medicine, 2014, 6, 6
  19. 19
    Orson W. Moe, Makoto Kuro-o, Fibroblast growth factor 23 and uremic vascular calcification: is it time to escalate from biomarker status to pathogenic agent?, Kidney International, 2014, 85, 5, 1022

    CrossRef

  20. 20
    Jocelyn S. Garland, Rachel M. Holden, Robert Ross, Michael A. Adams, Robert L. Nolan, Wilma M. Hopman, A. Ross Morton, Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3–5 chronic kidney disease patients, Journal of Diabetes and its Complications, 2014, 28, 1, 61

    CrossRef

  21. 21
    A. Fragoso, A. P. Silva, K. Gundlach, J. Buchel, P. L. Neves, Magnesium and FGF-23 are independent predictors of pulse pressure in pre-dialysis diabetic chronic kidney disease patients, Clinical Kidney Journal, 2014, 7, 2, 161

    CrossRef

  22. 22
    E. Michael Lewiecki, John P. Bilezikian, Lynda Bonewald, Juliet E. Compston, Robert P. Heaney, Douglas P. Kiel, Paul D. Miller, John T. Schousboe, Osteoporosis Update: Proceedings of the 2013 Santa Fe Bone Symposium, Journal of Clinical Densitometry, 2014, 17, 3, 330

    CrossRef

  23. 23
    Jasmine D Kerr, Rachel M Holden, Alexander R Morton, Robert L Nolan, Wilma M Hopman, Cynthia M Pruss, Jocelyn S Garland, Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease, BMC Nephrology, 2013, 14, 1, 26

    CrossRef

  24. 24
    Justine Bacchetta, Isidro B. Salusky, Martin Hewison, Beyond mineral metabolism, is there an interplay between FGF23 and vitamin D in innate immunity?, Pediatric Nephrology, 2013, 28, 4, 577

    CrossRef

  25. 25
    U. K. Møller, S. Streym, L. Mosekilde, L. Heickendorff, A. Flyvbjerg, J. Frystyk, L. T. Jensen, L. Rejnmark, Changes in calcitropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study, Osteoporosis International, 2013, 24, 4, 1307

    CrossRef

  26. 26
    Myles Wolf, Todd A Koch, David B Bregman, Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women, Journal of Bone and Mineral Research, 2013, 28, 8
  27. 27
    Justine Bacchetta, Jessica L Sea, Rene F Chun, Thomas S Lisse, Katherine Wesseling-Perry, Barbara Gales, John S Adams, Isidro B Salusky, Martin Hewison, Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes, Journal of Bone and Mineral Research, 2013, 28, 1
  28. 28
    Djalila Mekahli, Justine Bacchetta, From bone abnormalities to mineral metabolism dysregulation in autosomal dominant polycystic kidney disease, Pediatric Nephrology, 2013, 28, 11, 2089

    CrossRef

  29. 29
    Wei Yao, Weiwei Dai, Jean X. Jiang, Nancy E. Lane, Glucocorticoids and osteocyte autophagy, Bone, 2013, 54, 2, 279

    CrossRef

  30. 30
    Shirley Yumi Hayashi, Jacek Nowak, Bengt Lindholm, Marcelo Mazza do Nascimento, Britta Lind, Anna Bjällmark, Matilda Larsson, Maria Aparecida Pachaly, Astrid Seeberger, Miguel C. Riella, Lars-Åke Brodin, Left ventricular mechanical dyssynchrony in patients with different stages of chronic kidney disease and the effects of hemodialysis, Hemodialysis International, 2013, 17, 3
  31. You have free access to this content31
    John J.B. Anderson, Potential health concerns of dietary phosphorus: cancer, obesity, and hypertension, Annals of the New York Academy of Sciences, 2013, 1301, 1
  32. 32
    Paul D Miller, Sophie A Jamal, Pieter Evenepoel, Richard Eastell, Steven Boonen, Renal safety in patients treated with bisphosphonates for osteoporosis: A review, Journal of Bone and Mineral Research, 2013, 28, 10
  33. 33
    Keith A Hruska, Mary Leonard, Renata Pereira, Kenneth E White, Orson W Moe, The pathophysiology of the chronic kidney disease–mineral bone disorder: synopsis of a symposium at the Sun Valley Musculoskeletal Biology Workshop, IBMS BoneKEy, 2013, 10,

    CrossRef

  34. 34
    Said Kamel, Tilman Drueke, Ziad Massy, Troubles minéraux et osseux de la maladie rénale chronique (TMO-MRC), Revue Francophone des Laboratoires, 2013, 2013, 455, 29

    CrossRef

  35. 35
    Ann Young, Anthony B. Hodsman, Neil Boudville, Colin Geddes, John Gill, David Goltzman, Sarbjit Vanita Jassal, Scott Klarenbach, Gregory Knoll, Norman Muirhead, G.V. Ramesh Prasad, Darin Treleaven, Amit X. Garg, Bone and Mineral Metabolism and Fibroblast Growth Factor 23 Levels After Kidney Donation, American Journal of Kidney Diseases, 2012, 59, 6, 761

    CrossRef

  36. 36
    Paul D. Miller, Sophie A. Jamal, Sarah L. West, Bone Mineral Density in Chronic Kidney Disease Use and Misuse, Clinical Reviews in Bone and Mineral Metabolism, 2012, 10, 3, 163

    CrossRef

  37. 37
    Véronique Breuil, Liana Euller-Ziegler, Diabètes phosphatés, Revue du Rhumatisme Monographies, 2012, 79, 4, 253

    CrossRef

  38. 38
    JESÚS MONTENEGRO, IÑAKI CORNAGO, ISABEL GALLARDO, PAULA GARCÍA-LEDESMA, AINHOA HERNANDO, ISABEL MARTINEZ, ROSA I MUÑOZ, MARCO A ROMERO, Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis, Nephrology, 2012, 17, 1
  39. 39
    Olena Andrukhova, Ute Zeitz, Regina Goetz, Moosa Mohammadi, Beate Lanske, Reinhold G. Erben, FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2–SGK1 signaling pathway, Bone, 2012, 51, 3, 621

    CrossRef

  40. 40
    Matthew M. Riggs, Mark C. Peterson, Marc R. Gastonguay, Multiscale Physiology-Based Modeling of Mineral Bone Disorder in Patients With Impaired Kidney Function, The Journal of Clinical Pharmacology, 2012, 52, S1
  41. 41
    M. Ketteler, K. J. Martin, M. Cozzolino, D. Goldsmith, A. Sharma, S. Khan, E. Dumas, M. Amdahl, S. Marx, P. Audhya, Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study, Nephrology Dialysis Transplantation, 2012, 27, 5, 1942

    CrossRef

  42. 42
    Grahame J. Elder, Pathophysiology of CKD-MBD, Clinical Reviews in Bone and Mineral Metabolism, 2012, 10, 3, 128

    CrossRef

  43. 43
    Xiaoju Liu, Yubin Chen, Xiaoping Wu, Haiyan Li, Chao Jiang, Haishan Tian, Lu Tang, Dezhong Wang, Ting Yu, Xiaokun Li, SUMO fusion system facilitates soluble expression and high production of bioactive human fibroblast growth factor 23 (FGF23), Applied Microbiology and Biotechnology, 2012, 96, 1, 103

    CrossRef

  44. 44
    Mark R. Haussler, G. Kerr Whitfield, Ichiro Kaneko, Ryan Forster, Rimpi Saini, Jui-Cheng Hsieh, Carol A. Haussler, Peter W. Jurutka, The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis, Reviews in Endocrine and Metabolic Disorders, 2012, 13, 1, 57

    CrossRef

  45. 45
    Myles Wolf, Update on fibroblast growth factor 23 in chronic kidney disease, Kidney International, 2012, 82, 7, 737

    CrossRef

  46. 46
    Justine Bacchetta, Pierre Cochat, Isidro B Salusky, Katherine Wesseling-Perry, Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function, Pediatric Nephrology, 2012, 27, 7, 1131

    CrossRef

  47. 47
    Harald Jüppner, Myles Wolf, αKlotho: FGF23 coreceptor and FGF23-regulating hormone, Journal of Clinical Investigation, 2012, 122, 12, 4336

    CrossRef

  48. 48
    Clemens Bergwitz, Harald Jüppner, Pediatric Bone, 2012,

    CrossRef

  49. 49
    Daniella Magen, Israel Zelikovic, Pediatric Bone, 2012,

    CrossRef

  50. 50
    Peter Jurutka, G Whitfield, Ryan Forster, Shane Batie, Jamie Lee, Mark Haussler, Vitamin D, 2012,

    CrossRef

  51. 51
    P. Manghat, I. Souleimanova, J. Cheung, A.S. Wierzbicki, D.J. Harrington, M.J. Shearer, P. Chowiencki, I. Fogelman, M. Nerlander, D. Goldsmith, G. Hampson, Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD), Bone, 2011, 48, 5, 1127

    CrossRef

  52. 52
    Stacey M Woo, Jennifer Rosser, Vladimir Dusevich, Ivo Kalajzic, Lynda F Bonewald, Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo, Journal of Bone and Mineral Research, 2011, 26, 11
  53. 53
    Athina Markou, Vassiliki Tsiama, Symeon Tournis, Labrini Papanastasiou, Vaios Tsiavos, Aikaterini Dassou, Vasiliki Vlachou, Eugenia Papaliodi, Niki Asimaki, George Zografos, George Piaditis, Coexistence of Tumor-Induced Osteomalacia and Primary Hyperparathyroidism, Endocrine Practice, 2011, 17, 6, e144

    CrossRef

  54. 54
    Donald A. Molony, Brett W. Stephens, Derangements in Phosphate Metabolism in Chronic Kidney Diseases/Endstage Renal Disease: Therapeutic Considerations, Advances in Chronic Kidney Disease, 2011, 18, 2, 120

    CrossRef

  55. 55
    A. Trombetti, L. Richert, K. Hadaya, J.-D. Graf, F. R. Herrmann, S. L. Ferrari, P.-Y. Martin, R. Rizzoli, Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels, European Journal of Endocrinology, 2011, 164, 5, 839

    CrossRef

  56. 56
    J. Bacchetta, P. Cochat, I.B. Salusky, FGF23 et Klotho : les nouveaux incontournables du métabolisme phosphocalcique, Archives de Pédiatrie, 2011, 18, 6, 686

    CrossRef

  57. 57
    David J. A. Goldsmith, John Cunningham, Mineral metabolism and vitamin D in chronic kidney disease—more questions than answers, Nature Reviews Nephrology, 2011, 7, 6, 341

    CrossRef

  58. 58
    Nancy E Lane, Wei Yao, New insights into the biology of glucocorticoid-induced osteoporosis, IBMS BoneKEy, 2011, 8, 5, 229

    CrossRef

  59. 59
    E. Michael Lewiecki, John P. Bilezikian, Sundeep Khosla, Robert Marcus, Michael R. McClung, Paul D. Miller, Nelson B. Watts, Michael Maricic, Osteoporosis Update From the 2010 Santa Fe Bone Symposium, Journal of Clinical Densitometry, 2011, 14, 1, 1

    CrossRef

  60. 60
    Jerry Yee, Phosphate Enters the Syzygy, Advances in Chronic Kidney Disease, 2011, 18, 2, 55

    CrossRef

  61. 61
    Joachim H. Ix, Michel Chonchol, Gail A. Laughlin, Michael G. Shlipak, Mary A. Whooley, Relation of Sex and Estrogen Therapy to Serum Fibroblast Growth Factor 23, Serum Phosphorus, and Urine Phosphorus: The Heart and Soul Study, American Journal of Kidney Diseases, 2011, 58, 5, 737

    CrossRef

  62. 62
    Christian A. Waimann, Huifang Lu, Maria E. Suarez Almazor, Rheumatic Manifestations of Primary and Metastatic Bone Tumors and Paraneoplastic Bone Disease, Rheumatic Disease Clinics of North America, 2011, 37, 4, 527

    CrossRef

  63. 63
    WILLIAM G PETCHEY, DAVID W JOHNSON, NICOLE M ISBEL, Shining D' light on chronic kidney disease: Mechanisms that may underpin the cardiovascular benefit of vitamin D, Nephrology, 2011, 16, 4
  64. You have free access to this content64
    Lynda F Bonewald, The amazing osteocyte, Journal of Bone and Mineral Research, 2011, 26, 2
  65. 65
    Keith A. Hruska, Suresh Mathew, The Roles of the Skeleton and Phosphorus in the CKD Mineral Bone Disorder, Advances in Chronic Kidney Disease, 2011, 18, 2, 98

    CrossRef

  66. 66
    REBEKAH GRAYSON, MARTIN HEWISON, VITAMIN D AND HUMAN PREGNANCY, Fetal and Maternal Medicine Review, 2011, 22, 01, 67

    CrossRef

  67. 67
    Robert P. Heaney, Phosphorus,